miR-21 has also been shown to act as an upstream regulator of IL-10, specifically as a negative regulator of IL-10-producing regulatory B (IL-10+ Breg) cells which promote tolerance in autoimmune diseases (55). The gene discussed is IL10; the disease is autoimmune disease.